US 6197926
Methods for treatment of diabetes using peptide analogues of insulin
expired A61KA61K38/00A61P
Quick answer
US patent 6197926 (Methods for treatment of diabetes using peptide analogues of insulin) held by Neurocrine Biosciences, Inc. expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/00, A61P, A61P3/10, A61P5/50